Ozempic parent’s stock having worst day since the 1980s as new weight-loss drug disappoints
Novo Nordisk’s stock dives as new weight loss drug disappoints in a late-stage trial, which gave a boost to Eli Lilly shares.
A next-gen Ozempic falls short in a drug trial — and Novo Nordisk stock plunges 20%
Novo Nordisk (NVO) released mixed clinical-trial results for its potential Ozempic successor on Friday, leaving Wall Street ...
Newsweek8d
Elon Musk Calls Himself 'Ozempic Santa' In Festive New Photo
The Space X founder, who has shed a noticeable amount of weight, reveals he has taken GLP-1 medications Ozempic and Mounjaro. Marc Piasecki/Getty Images He noted that the correct medication ...
Yahoo24d
Kelly Ripa Fans Go Wild After She Shares 'Stunning' Photo of Her 'Ozempic' Christmas Tree
Kelly Ripa's latest social media post has her fans thinking someone might be using Ozempic—but it's not ... the Live with Kelly and Mark co-host shared a photo of her decked-out tree covered ...
MarketWatch14d
Ozempic parent’s stock having worst day since the 1980s as new weight-loss drug disappoints
That news was welcome to rival Eli Lilly and Co., which makes weight-loss drugs Zepbound and Mounjaro that compete with Novo Nordisk’s Wegovy and Ozempic. Tomi Kilgore is MarketWatch's deputy ...